Laboratory News and Research

RSS

Rare compound found in a shrub could help fight previously 'undruggable' cancer protein

A chemist from Purdue University has found a way to synthesize a compound to fight a previously "undruggable" cancer protein with benefits across a myriad of cancer types.

20 Apr 2021

All-in-one test provides a promising solution for COVID-19 detection and mutational surveillance

A new type of COVID-19 testing strategy could help streamline the process of identifying cases, tracking variants and detecting co-infecting viruses.

20 Apr 2021

Personal and work-related factors can increase risk for neck pain

With roughly 80% of jobs being sedentary, often requiring several hours of sitting stooped in front of a computer screen, neck pain is a growing occupational hazard. Smartphones and other devices have also caused people to bend their necks for prolonged periods. But is bad posture solely to blame?

20 Apr 2021

INTEGRA introduces its portable 96 channel pipette at the most affordable price

INTEGRA Biosciences has launched the MINI 96 portable electronic pipette, giving every lab access to significantly increased liquid handling productivity.

From INTEGRA Biosciences 20 Apr 2021

New nanomedicine device is effective for treating glioblastoma multiforme

A micro-sized polymeric net wrapping around brain tumors, just like a fishing net around a shoal of fish: this is the microMESH, a new nanomedicine device capable to conform around the surface of tumor masses and efficiently deliver drugs.

20 Apr 2021

New machine-learning program accurately identifies COVID-19 conspiracy theories on social media

A new machine-learning program accurately identifies COVID-19-related conspiracy theories on social media and models how they evolved over time--a tool that could someday help public health officials combat misinformation online.

20 Apr 2021

New infectious hospital framework employs robotic tools for pandemic mitigation

In December 2019, a new viral infection was detected in Wuhan, China. On January 30, 2020, the World Health Organization declared the outbreak a public health emergency of international concern, and on March 11, the COVID-19 pandemic.

19 Apr 2021

Simple dietary supplement ameliorates schizophrenic traits in mice

A simple dietary supplement reduces behavioral symptoms in mice with a genetic mutation that causes schizophrenia.

19 Apr 2021

COVID-19 pandemic has created major changes in delivery of MS care

A survey of U.S. multiple sclerosis, or MS, specialist clinicians reveals the COVID-19 pandemic has created major changes in how they deliver care.

19 Apr 2021

MIPT and Harvard researchers grow and transplant retinal ganglion cells to treat glaucoma

A joint research carried out by MIPT scientists and Harvard researchers have presented retinal cells that can integrate into the retina.

19 Apr 2021

New COVID-19 vaccine could provide protection against existing and future strains of coronaviruses

A COVID-19 vaccine that could provide protection against existing and future strains of the COVID-19 coronavirus, and other coronaviruses, and cost about $1 a dose has shown promising results in early animal testing.

19 Apr 2021

Household income explains more discrepancy in food security than any other factor

One of the most comprehensive statistical analyses of drivers of food insecurity across 65 countries has concluded that household income consistently explains more discrepancy in food security than any other factor, including agricultural land resources and production.

19 Apr 2021

Competition and natural selection drive the size discrepancy of sperm and egg cell

In most living animals, egg cells are vastly larger than sperm cells. In humans, for example, a single egg is 10 million times the volume of a sperm cell.

19 Apr 2021

Humans versus viruses - Can we avoid extinction in near future?

Expert argues that human-caused changes to the environment can lead to the emergence of pathogens, not only from outside but also from our own microbiome, which can pave the way for large-scale destruction of humans and even our extinction.

19 Apr 2021

Obesity, hypertension and smoking linked to lower vaccine-induced antibody production against SARS-CoV-2

In a recent study posted to the medRxiv preprint server, a research group from Italy has demonstrated that the antibody response can be blunted in subjects with certain risk factors shortly after the second dose of mRNA vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

18 Apr 2021

Research looks at SARS-CoV-2 transmission from people to pets

A large team of researchers from the US demonstrated that pets with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) likely acquired the putative virus from humans. This suggests that human-animal infection may actually occur much more frequently than previously thought – implying that infected individuals should limit their contact with animals.

18 Apr 2021

FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19

Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients.

17 Apr 2021

Supercomputer simulations illuminate the behavior of dominant G form of SARS-CoV-2

Large-scale supercomputer simulations at the atomic level show that the dominant G form variant of the COVID-19-causing virus is more infectious partly because of its greater ability to readily bind to its target host receptor in the body, compared to other variants.

17 Apr 2021

Candidate coronavirus vaccines show promising results in early animal testing

A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing.

17 Apr 2021

Experimental antiviral drug for COVID-19 shows effectiveness in hamster models

The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.

17 Apr 2021

Laboratory News and Research

Rare compound found in a shrub could help fight previously 'undruggable' cancer protein

All-in-one test provides a promising solution for COVID-19 detection and mutational surveillance

Personal and work-related factors can increase risk for neck pain

INTEGRA introduces its portable 96 channel pipette at the most affordable price

New nanomedicine device is effective for treating glioblastoma multiforme

New machine-learning program accurately identifies COVID-19 conspiracy theories on social media

New infectious hospital framework employs robotic tools for pandemic mitigation

Simple dietary supplement ameliorates schizophrenic traits in mice

COVID-19 pandemic has created major changes in delivery of MS care

MIPT and Harvard researchers grow and transplant retinal ganglion cells to treat glaucoma

New COVID-19 vaccine could provide protection against existing and future strains of coronaviruses

Household income explains more discrepancy in food security than any other factor

Competition and natural selection drive the size discrepancy of sperm and egg cell

Humans versus viruses - Can we avoid extinction in near future?

Obesity, hypertension and smoking linked to lower vaccine-induced antibody production against SARS-CoV-2

Research looks at SARS-CoV-2 transmission from people to pets

FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19

Supercomputer simulations illuminate the behavior of dominant G form of SARS-CoV-2

Candidate coronavirus vaccines show promising results in early animal testing

Experimental antiviral drug for COVID-19 shows effectiveness in hamster models

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo